by Charlotte Cecil
Mental illness is one of the leading causes of disability around the world, affecting one in three people every year in Europe alone – at an estimated cost of over €460 billion. It is hugely disruptive to the lives of individuals, their families and to wider communities.
If we are to successfully rise to the challenge of understanding how mental health disorders develop – and therefore how best they may be prevented – we must wind back the clock to children’s early development. More than half of all diagnosable mental health problems start before the age of 14, and often manifest earlier in childhood as emotional and behavioural problems, such as anxiety, depression, aggression or hyperactivity.
Marlene Lorgen-Ritchie is a postdoctoral research fellow at the Rowett Institute. Her research involves investigating the biological pathways linking the social environment during development, with mood and personality in later life.
Here, in the latest of our biosocial blog series, she writes about one aspect of biosocial research – epigenetics – which she’ll be exploring more at a Festival of Social Science event next week.
Our early life experiences in the womb and throughout childhood have been shown to influence how we turn out as adults. This includes how healthy we are, how rich we become and what and how we think. However we still don’t know how it all comes about biologically. That’s where epigenetics comes in. Continue reading
Today marks 20 years since Dolly the Sheep was unveiled to the world by British scientists, at BBSRC’s Roslin Institute – which this month welcomed the appointment of a new director. Here ESRC-funded academic Sarah Franklin, who authored the book Dolly Mixtures, looks at where we currently stand on the ethics surrounding cloning.
A designer sheep
On 22 February 1997 the world woke up to a new phenomenon: a cloned Scottish sheep named Dolly. She became a global superstar: famous because she was a completely normal sheep. Dolly embodied a famously misunderstood scientific technique, namely cloning. Continue reading
Dr Matthias Wienroth is researcher and knowledge broker at the interface of the sociology of science and technology, public and policy engagement, ethics, and governance studies. He is part of the FP7 European Forensic Genetics (EUROFORGEN) Network of Excellence and Research Fellow at Northumbria University; he is also Visiting Researcher at the Policy, Ethics and Life Sciences (PEALS) Research Centre, Newcastle University.
Here, in the latest of our biosocial blog series, he discusses the role of DNA and the research discussed in the ESRC-funded seminar series ‘Genetics, technology, security and justice: Crossing, contesting and comparing boundaries’
DNA evidence is often portrayed as vital to criminal investigations and trials. Just over 30 years ago, in 1984, Alec Jeffreys and his team at Leicester University discovered DNA profiling. In its first application it helped to exonerate one suspect and then build the case for the conviction of another. Today, DNA analysis is often perceived to be the ‘gold standard’ for evidence. Continue reading
Dr Victoria Leong
Dr Sam Wass
In the latest in our series of biosocial blogs, Dr Victoria Leong, an ESRC Transformative Research Grant holder, and Dr Sam Wass, an ESRC Future Research Leader, talk about their research, which takes a new perspective on understanding how babies learn from their parents.
William James, the founding father of psychology, once declared that “Everyone knows what attention is. It is taking possession of the mind, in clear and vivid form, of one out of what seems several simultaneously possible objects or trains of thought. Focalisation, concentration of consciousness are of its essence. It implies a withdrawal from some things in order to deal effectively with others.”
Since then, the vast majority of researchers have followed his approach of assuming that attention (or concentration, in layman’s terms) is a property of individual minds, to be studied in isolation. Continue reading